Enhanced percutaneous permeability of nicardipine hydrochloride by carvone across the rat abdominal skin

Drug Development and Industrial Pharmacy

Volumn 29, Issue 2, 2003, Pages 191-202

  Krishnaiah, Y S R ^a   Satyanarayana, V ^a   Bhaskar, P ^a  

^a ANDHRA UNIVERSITY   (India)

Author keywords

Carvone; DSC; FT IR; HPC gels; In vitro transdermal permeability; Nicardipine hydrochloride; Rat abdominal skin

Indexed keywords

CARVONE; HYDROXYPROPYLCELLULOSE; NICARDIPINE;

ABDOMINAL WALL MUSCULATURE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; DRUG DETERMINATION; DRUG HALF LIFE; DRUG STABILITY; EPIDERMIS CELL; FIRST PASS EFFECT; FOURIER TRANSFORMATION; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; RAT; SCANNING PROBE MICROSCOPY; SKIN PERMEABILITY; SOLUBILITY; STRATUM CORNEUM;

ABDOMEN; ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, CUTANEOUS; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; CELLULOSE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMIS; GELS; MALE; MONOTERPENES; NICARDIPINE; PERMEABILITY; RATS; SKIN ABSORPTION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TERPENES; TIME FACTORS;

EID: 0037219906     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120016727     Document Type: Article

References (56)

1. Graham, D.J.M.; Dow, R.J.; Hall, D.J.; Alexander, O.F.; Mroszczat, E.J.; Freedman, D. The metabolism and pharmacokinetics of nicardipine hydrochloride in man. Br. J. Clin. Pharmacol. 1985, 20, 235-285.
2. Dow, R.J.; Graham, D.J.M. A review of the human: metabolism and pharmacokinetics of nicardipine hydrochloride. Br. J. Clin. Pharmacol. 1986, 22, 1955-2025.
3. Krishnaiah, Y.S.R.; Satyanarayana, V.; Karthikeyan, R.S. Effect of solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis. J. Pharm. Pharmaceut. Sci. 2002, 5, 124-130.
4. Zettersten, E.M.; Ghadially, K.R.; Feingold, D.; Crumrine, A.; Elias, P.M. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin. J. Am. Acad. Dermatol. 1997, 37, 403-408.
5. Elias, P.M. The stratum corneum revisited. J. Derm. 1996, 23, 756-758.
6. Mao-Qiang, M.; Feingold, K.R.; Elias, P.M. Inhibition of cholesterol and sphingolipid synthesis causes paradoxical effects on permeability barrier homeostasis. J. Invest. Dermatol. 1993, 1011, 85-90.
7. Gao, S.; Singh, J. In vitro percutaneous absorption enhancement of lipophilic drug tamoxifen by terpenes. J. Control Rel. 1998, 51, 193-199.
8. Valpato, N.; Nicoli, S.; Laureri, C.; Colombo, P.; Santi, P. In vitro acyclovir delivery in human layers after transdermal iontophoresis. J. Control. Rel. 1998, 50, 291-296.
9. Wang, Su.; Kara, M.; Krishnan, T. Transdermal delivery of cyclosporin-A using electroporation. J. Control. Rel. 1998, 50, 61-70.
10. Asano, J.; Suisha, F.; Takada, M.; Kawasaki, N.; Miyazaki, S. Effect of pulsed output ultra sound on the transdermal absorption of indomethacin from an ointment in rats. Biol. Pharm. Bull. 1997, 20, 288-291.
11. Kuratomi, Y.; Miyauchi, K. Methods and instruments of moxibustion. US patent 1988, 747 (4), 841.
12. Davis, A.; Hadgraft, J. Effect of supersaturation on membrane transport. I. Hydrocortisone acetate. Int. J. Pharm. 1991, 76, 1-8.
13. Bando, H.; Sahashi, M.; Yamashita, F.; Takakura, Y.; Hashida, M. In vivo evaluation of acyclovir prodrug penetration and metabolism through rat skin using a diffusion/bioconversion model. Pharm. Res. 1997, 14, 56-62.
14. Cevc, G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetartion, and transdermal drug delivery. Crit. Rev. Ther. Drug Carr. Syst. 1996, 13, 257-388.
15. Barry, B.W. Dermatological formulations: Percutaneous Absorption; Dekker: New York, 1983.
16. Seki, T.; Suginayashi, K.; Juni, K.; Morimoto, Y. Percutaneous absorption enhancer applied to membrane permeation-controlled transdermal delivery of nicardipine hydrochloride. Drug Des. Deliv. 1989, 4, 69-75.
17. Kobayashi, D.; Mastsuzawa, T.; Sugibayashi, K.; Morimoto, Y.; Kobayashi, M.; Kimura, M. Feasibility of use of several cardiovascular agents in transdermal therapeutic systems with l-menthol-ethanol system on hairless rat and human skin. Biol. Pharm. Bull. 1993, 16 (3), 254-258.
18. El-Kattan, A.F.; Asbill, C.S.; Kim, N.; Michniak, B.B. The effect of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int. J. Pharm. 2001, 215, 229-240.
19. Krishnaiah, Y.S.R.; Satyanarayana, V.; Karthikeyan, R.S. Penetration enhancing effect of menthol on the percutaneous absorption of nicardipine hydrochloride from HPC gel through excised rat epidermis. Pharm. Dev. Tech. 2002, 7, 305-316.
20. Hori, M.; Satoch, H.; Miabach, H.I.; Guy, R.H. Enhancement effect of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity. J. Pharm. Sci. 1991, 80, 32-35.
21. Zhao, K.; Singh, J. In vitro percutaneous absorption of propranolol hydrochloride through porcine epidermis by terpenes/ethanol. J. Control. Rel. 1999, 62, 359-366.
22. Hanif, R.M.; Qineng, P.; Zhan, G. Penetration enhancing effect of terahydrogeraniol on the percutaneous absorption of 5-fluorouracil form gels in excised rat skin. J. Control. Rel. 1998, 55, 297-302.
23. Arellano, A.; Santoyo, S.; Martin, C.; Ygartua, P. Enhancing effect of terpenes on the in vito percutaneous absorption of diclofenac sodium. Int. J. Pharm. 1996, 130, 141-145.
24. Cornwell, P.; Barry, B. Sequiterpene components of volatile oil as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J. Pharm. Pharmacol. 1991, 46, 261-269.
25. Cornwell, P.; Barry, B. Wide angle X-ray diffraction of human stratum corneum effect of hydration and terpene enhancer treatment. J. Pharm. Pharmacol. 1994, 46, 938-950.
26. Morimoto, Y.; Sugibayashi, K.; Kobayashi, D.; Shoji, H.; Yamazaki, J.; Kimura, M. A new enhancer/coenhancer system to increase skin permeation of morphine hydrochloride in vitro. Int. J. Pharm. 1993, 91, 9-14.
27. Kunta, J.R.; Goskonda, V.R.; Brotherton, H.O.; Khan, M.A.; Reddy, I.K. Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J. Pharm. Sci. 1997, 86, 1369-1373.
28. Okabe, H.; Takayama, K.; Ogura, A.; Nagai, T. Effects of limonene and related compounds on the percutaneous absorption of indomethacin. Drug Design. Del. 1989, 4, 313-321.
29. Okabe, H.; Obata, Y.; Takayama, K.; Nagai, T. Percutaneous absorption enhancing effect of and skin irritation of monocyclic monoterpenes. Drug Des. Deliv. 1990, 6, 229-238.
30. Zhao, K.; Singh, J. Mechanism of percutaneous absorption of tamoxifen by terpenes: euginol, D-lemonene and menthol. J. Control. Rel. 1998, 55, 253-260.
31. Takayama, K.; Kitkuchi, K.; Obata, Y.; Okabe, H.; Machida, Y.; Nagai, T. Terpenes as percutaneous absorption promoters. STP Pharma. Sci. 1991, 1, 83-88.
32. Walker, R.B.; Smith, E.W. The role of percutaneous penetration enhancers. Adv. Drug Deliv. Rev. 1996, 18, 295-301.
33. Obata, Y.; Takayama, K.; Maitani, Y.; Machida, Y.; Nagai, T. The effect of ethanol on skin permeation of nonionized and ionized diclofenac. Int. J. Pharm. 1993, 89, 191-198.
34. Berner, B.; Otte, J.H.; Mazzenga, C.C.; Steffens, R.J.; Ebert, C.D. Ethanol: water mutually enhanced transdermal therapeutic system I: Nitroglycerine solution properties and membrane transport. J. Pharm. Sci. 1989, 78, 314-318.
35. Takahashi, K.; Tamagawa, S.; Kattagi, T.; Yoshitomi, H.; Kamada, A.; Rytting, J.; Nashihata, T.; Mizuno, N. In vitro transport of sodium diclofenac across rat abdominal skin: Effect of selection of oleaginous component and the addition of alcohols to the vehicle. Chem. Pharm. Bull. 1991, 39, 3097-3099.
36. El-Kattan, A.F.; Asbill, C.S.; Michniak, B.B. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int. J. Pharm. 2000, 198, 179-189.
37. Leonard, T.W.; Mikula, K.K.; Schlesinger, M.S. Carvone Enhancement of Transdermal Drug Delivery. US Patent 4888360, 1989.
38. Michniak, B.; Player, M.R.; Chapman, J.M.; Sowell, J.W. Azoneanalogues as penetration enhancers: effect of different vehicles on hydrocortisone acetate skin permeation and retention. J. Control. Rel. 1994, 32, 147-154.
39. Michniak, B.; Player, M.R.; Chapman, J.M.; Sowell, J.W. Optimization of dermal delivery using azone analogues as enhancers. Proc. 12th Pharm. Technol. Conf. 1993, 2, 158-173.
40. Yui, N.; Okuhara, M.; Okano, M.; Sakurai, Y. Change in water structure in the stratum corneum of hairless rat skin by subcutaneous enhancers and its effect on indomethacin permeation. Jpn. J. Drug Deliv. Syst. 1992, 7, 1199-1203.
41. Bhatia, K.S.; Gao, S.; Singh, J. Effect of penetration enhancers and iontophoresis on FT-IR spectroscopy and LHRH permeability through porcine skin. J. Control. Rel. 1997, 47, 81-89.
42. Casal, H.L.; Mantsch, H.H. Polymeric phase behavior of phospolipid membranes studied by infrared spectroscopy. Biochim. Biophys. Acta 1984, 779, 381-401.
43. Okamoto, H.; Hashida, M.; Sezaki, H. Structure-activity relationship of 1-alkyl or 1-alkylzacycloalkanones derivatives as percutaneous penetration enhancers. J. Pharm. Sci. 1988, 77, 418-424.
44. Hayton, W.L.; Chen, T. Correction of perfusate concentration samples removal. J. Pharm. Sci. 1981, 71, 820-821.
45. Julraht, K.; Keith, A.P.; James, A.W. Development of a transdermal delivery device for melotoin in vitro study. Drug. Dev Ind. Pharm. 1995, 21, 1377-1387.
46. Ho, H.O.; Chen, L.C.; Lin, H.M.; Sheu, M.T. Penetration enhancement by menthol combined with a solubulization effect in a solvent system. J. Control. Rel. 1998, 51, 301-311.
47. Yamune, M.; Williams, A.; Barry, B. Terpenes penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action. J. Pharm. Pharmacol. 1995, 47, 978-989.
48. Williams, A.; Barry, B. Terpenes and the lipidprotein partitioning theory of skin penetration enhancement. Pharm. Res. 1991, 8, 17-24.
49. Yamune, M.A.; Williams, A.C.; Barry, B.W. Effects of terpene and oleic acid as skin penetration enhancer towards 5-fluorouracil as assessed with time; permeation, partitioning and differential scaning calorometry. Int. J. Pharm. 1995, 116, 237-251.
50. Kurihara-Bergstrom, T.; Knutson, K.; DeNoble, L.J.; Goates, C.Y. Percutaneous absorption enhancement of an ionic molecule by ethanolwater system in human skin. Pharm. Res. 1990, 7, 762-766.
51. Goates, C.Y.; Knutson, K. Enhanced permeation of polar compounds through human epidermis. I. Permeability and membrane structural changes in the presence of short chain alcohols. Biochem. Biophys. Acta. 1994, 1195, 169-179.
52. Takahashi, K.; Sakano, H.; Yoshida, M.; Numata, N.; Mizuno, N. Characterization of the influences of polyol fatty acid esters on the permeation of diclofenac through rat skin. J. Control. Rel. 2001, 73, 351-358.
53. Golden, G.M.; Guzek, D.B.; Harris, R.R.; MeKie, J.E.; Pous, R.O. Lipid thermotropic transition in human stratum corneum. J. Invest. Dermatol. 1986, 86, 255-269.
54. Yum, S.; Lee, E.; Taskovich, L.; Theeuwes, F. Permeation enhancement with ethanol: mechanism of action through skin. In Drug Permeation Enhancement; Hsich, D.S., Ed.; Marcel Dekker: New York, 1994; 143-170.
55. Brandys, J.F.; Hu, C.Q.; Lin, L. A simple model for proteins with interacting domains. Applications to scanning calorimetry data. Biochemistry 1989, 28, 8588-8596.
56. Takayama, K.; Kikuchi, K.; Obata, Y.; Okabe, H.; Machida, Y.; Nagai, T. Terpenes as percutaneous absorption promoters. STP Pharm. Sci. 1993, 183, 25-30.